info@ucallmlabs.com
Protein‑macromolecule interaction
Protein‑macromolecule interactions serve as the fundamental basis for cellular signal transduction, metabolic regulation, immune responses, and gene expression, with their dysregulation frequently associated with cancer, autoimmune diseases, and neurodegenerative disorders. Consequently, investigating these interactions is of great significance for understanding disease mechanisms and identifying therapeutic targets. Commonly employed techniques include affinity purification‑based pull‑down assays (such as peptide pull‑down, lipid pull‑down, and glycan pull‑down) and Co‑IP (such as protein‑peptide interaction Co‑IP, protein‑lipid interaction Co‑IP, protein‑glycan interaction Co‑IP), which enable the elucidation of direct or indirect interactions between proteins and peptides, lipids, glycans, or other proteins at both in vitro and in vivo levels.
1. Pull‑down
1.1 Peptide Pull‑down
1.1.1 Introduction
Peptide pull‑down (PPD) is an in vitro affinity purification technique used to detect and identify proteins that interact with specific peptide sequences. In this method, biotinylated synthetic peptides serve as “baits” immobilized on streptavidin‑coated magnetic or agarose beads. After incubation with cell lysates or nuclear extracts, non‑specifically bound proteins are removed through washing steps, and specific interacting proteins are eluted and enriched for subsequent analysis by SDS‑PAGE, Western Blot, or mass spectrometry (LC‑MS/MS). PPD is particularly suited for studying protein‑protein interactions mediated by short linear motifs (SLiMs) and for investigating the regulatory effects of post‑translational modifications (e.g., histone modifications) on protein interactions. When combined with quantitative proteomic approaches such as SILAC (Stable Isotope Labeling by Amino Acids in Cell Culture), PPD can effectively discriminate specific interactors from background noise, enabling high‑sensitivity interactome screening.
1.1.2 Products
1.1.3 Applications
| Application | Description |
|---|---|
| Identification of histone modification 'Reader' proteins | Use biotinylated histone tail peptides bearing specific PTMs (e.g., methylation, acetylation, phosphorylation) as baits to capture “reader” proteins that specifically recognize these modifications from nuclear extracts, systematically dissecting epigenetic regulatory mechanisms. |
| Validation of protein interactions mediated by short linear motifs (SLiMs) | Design synthetic peptides targeting short linear motifs within intrinsically disordered regions (IDRs) to validate their interactions with known protein domains (e.g., Kelch, SWIB, UEV), revealing the molecular basis of low‑affinity, transient protein‑protein interactions. |
| Study of how post‑translational modifications regulate protein interactions | Quantitatively analyze the impact of PTMs (phosphorylation, methylation, acetylation, etc.) on protein binding affinity and specificity by comparing pull‑down results between modified and unmodified peptides, deciphering PTM‑mediated regulation of protein interactions. |
| Analysis of the impact of disease‑related mutations on protein interactions | Employ competitive pull‑down assays with wild‑type versus mutant peptides to identify how disease‑associated mutations alter protein interaction networks, providing molecular insights into disease pathogenesis. |
| Screening for combinatorial PTM 'Reader' proteins | Use combinatorial PTM peptide libraries (e.g., a 5,000‑member PTM‑randomized histone H3 N‑terminus library) for high‑throughput pull‑down screening to identify “reader” proteins requiring specific PTM combinations for recognition. |
References:
- Vermeulen M, Eberl HC, Matarese F, Marks H, Denissov S, Butter F, Lee KK, Olsen JV, Hyman AA, Stunnenberg HG, Mann M. Quantitative interaction proteomics and genome‑wide profiling of epigenetic histone marks and their readers. Cell. 2010 Sep 17;142(6):967‑80. doi: 10.1016/j.cell.2010.08.020. PMID: 20850016.
- Eberl HC, Spruijt CG, Kelstrup CD, Vermeulen M, Mann M. A map of general and specialized chromatin readers in mouse tissues generated by label‑free interaction proteomics. Mol Cell. 2013 Jan 24;49(2):368‑78. doi: 10.1016/j.molcel.2012.10.026. Epub 2012 Nov 29. PMID: 23201125.
- Meyer K, Kirchner M, Uyar B, Cheng JY, Russo G, Hernandez‑Miranda LR, Szymborska A, Zauber H, Rudolph IM, Willnow TE, Akalin A, Haucke V, Gerhardt H, Birchmeier C, Kühn R, Krauss M, Diecke S, Pascual JM, Selbach M. Mutations in Disordered Regions Can Cause Disease by Creating Dileucine Motifs. Cell. 2018 Sep 20;175(1):239‑253.e17. doi: 10.1016/j.cell.2018.08.019. Epub 2018 Sep 6. PMID: 30197081.
- Stransky S, Saskya‑Joseph J, Sun Y, Sidoli S. Identification of Chromatin Readers Using a Peptide Pull‑Down and Mass Spectrometry Integrated Approach. Methods Mol Biol. 2025;2919:251‑266. doi: 10.1007/978‑1‑0716‑4486‑7_14. PMID: 40257567.
1.2 Lipid Pull‑down
1.2.1 Introduction
Lipid Pull‑down is an in vitro affinity purification technique used to systematically identify proteins that interact with specific lipid molecules. In this method, target lipids (e.g., phosphoinositides, sphingolipids, cholesterol) are immobilized on solid‑phase supports (such as agarose or magnetic beads) via covalent coupling or biotin‑avidin systems. After incubation with cell lysates or tissue extracts, non‑specifically bound proteins are removed through washing steps, and specific lipid‑interacting proteins are eluted and enriched for subsequent analysis by Western Blot or mass spectrometry. Lipid Pull‑down serves as a core tool for investigating lipid signaling, membrane protein recruitment, and lipid raft dynamics. It is widely applied to dissect protein‑binding networks of phosphoinositide phosphorylated derivatives, sphingolipid‑protein interactions, and cholesterol‑associated protein complexes. Combined with quantitative proteomics, this approach enables high‑throughput, high‑sensitivity screening of lipid‑binding proteins.
1.2.2 Products
1.2.3 Applications
| Applications | Description |
|---|---|
| Panoramic identification of phosphoinositide binding proteins | Use immobilized PI3P, PI4P, PI(4,5)P₂, PI(3,4,5)P₃ and other phosphoinositides as baits to capture and identify proteins that specifically recognize distinct phosphorylation states, systematically mapping organelle‑specific lipid‑protein interaction networks. |
| Lipid specific screening of FYVE/PH/PX domain proteins | Validate the lipid‑binding specificity of FYVE, PH, PX domain‑containing proteins for specific PIPs (e.g., PI3P for FYVE, PI(3,4,5)P₃ for PH) via lipid pull‑down, deciphering molecular mechanisms and subcellular localization functions of lipid recognition domains. |
| Identification of sphingolipid and cholesterol binding proteins | Screen proteins recognizing lipid raft microdomains using immobilized sphingomyelin (SM), ceramide (Cer), dihydrosphingomyelin (DHSM), and cholesterol beads, revealing membrane microdomain protein composition and signaling mechanisms. |
| Lipid target identification of pathogen effector proteins | Identify lipid targets of bacterial/parasitic effector proteins (e.g., oomycete RXLR effectors, Legionella effectors) to reveal molecular mechanisms by which pathogens hijack host lipid signaling for membrane targeting and immune evasion. |
| Study on how lipid modifications regulate protein interactions | Analyze how lipid chemical modifications regulate protein binding affinity and specificity by comparing pull‑down results across different lipid modification states, deciphering cross‑regulatory networks between lipid metabolism and signal transduction. |
References:
- Kutateladze TG. Translation of the phosphoinositide code by PI effectors. Nat Chem Biol. 2010 Jul;6(7):507‑13. doi: 10.1038/nchembio.390. PMID: 20559318; PMCID: PMC3182472.
- Stenmark H. Harald Stenmark: hands on FYVE‑fingers. Interview by Caitlin Sedwick. J Cell Biol. 2011 Feb 21;192(4):544‑5. doi: 10.1083/jcb.1924pi. PMID: 21339328; PMCID: PMC3044113.
- Morito M, Hata K, Izumi Y, Bamba T, Matsumori N. Comprehensive Identification of Lipid‑Membrane Protein Interactions via Advanced Proteomics and Extended Lipid‑Immobilized Bead Technology. Anal Chem. 2025 Apr 29;97(16):8880‑8889. doi: 10.1021/acs.analchem.5c00074. Epub 2025 Apr 15. PMID: 40233011; PMCID: PMC12044594.
- Kale SD, Gu B, Capelluto DG, Dou D, Feldman E, Rumore A, Arredondo FD, Hanlon R, Fudal I, Rouxel T, Lawrence CB, Shan W, Tyler BM. External lipid PI3P mediates entry of eukaryotic pathogen effectors into plant and animal host cells. Cell. 2010 Jul 23;142(2):284‑95. doi: 10.1016/j.cell.2010.06.008. Erratum in: Cell. 2010 Sep 17;142(6):981‑3. PMID: 20655469.
- Balla T. Phosphoinositides: tiny lipids with giant impact on cell regulation. Physiol Rev. 2013 Jul;93(3):1019‑137. doi: 10.1152/physrev.00028.2012. PMID: 23899561; PMCID: PMC3962547.
1.3 Glycan Pull‑down
1.3.1 Introduction
Glycan Pull‑down encompasses a family of affinity purification techniques based on carbohydrate‑protein interactions, utilizing immobilized carbohydrates (such as lectins, boronate affinity ligands, or glycan probes) as baits to specifically capture glycoproteins, glycopeptides, or carbohydrate‑binding proteins from complex biological samples. This technology represents one of the core tools in glycoproteomics and is widely applied in glycoprotein enrichment, glycan‑protein interaction identification, disease biomarker discovery, and drug target screening. Combined with mass spectrometry (LC‑MS/MS) analysis, Glycan Pull‑down enables highly sensitive detection of low‑abundance glycoproteins and site‑specific glycosylation characterization, providing critical technical support for understanding the roles of protein glycosylation in cellular signal transduction, immune responses, and disease pathogenesis.
1.3.2 Products
1.3.3 Applications
| Applications | Description |
|---|---|
| Glycoprotein Enrichment | Employ lectin affinity chromatography or boronate affinity chromatography to selectively enrich glycoproteins and glycopeptides from complex samples (serum, plasma, cell lysates), followed by LC‑MS/MS for site‑specific glycosylation identification and quantification. |
| Lectin‑Glycan Specificity | Systematically identify lectin binding specificity toward particular glycan structures using glycan arrays or lectin pull‑down approaches, constructing glycan‑protein interaction networks to provide molecular foundations for understanding cell recognition, pathogen infection, and immune response mechanisms. |
| Biomarker Discovery | Compare glycoprotein expression profiles and glycosylation patterns between disease and healthy samples, utilizing lectin pull‑down to enrich differentially glycosylated proteins, and identify disease‑specific glycosylation biomarkers for cancer and neurodegenerative diseases via mass spectrometry. |
| Host‑Pathogen | Identify interactions between viral (e.g., HIV, SARS‑CoV‑2) or bacterial surface glycoproteins and host cell receptors using glycan pull‑down techniques, elucidating pathogen invasion mechanisms and providing targets for vaccine development and antiviral drug design. |
| Enzyme Specificity | Capture glycosyltransferases or glycosidases using immobilized glycan substrate pull‑down, identify enzyme‑substrate complexes via mass spectrometry, and decipher substrate preferences and catalytic mechanisms of key enzymes in glycan biosynthesis and degradation pathways. |
References:
- Zhang H, Li XJ, Martin DB, Aebersold R. Identification and quantification of N‑linked glycoproteins using hydrazide chemistry, stable isotope labeling and mass spectrometry. Nat Biotechnol. 2003 Jun;21(6):660‑6. doi: 10.1038/nbt827. Epub 2003 May 18. PMID: 12754519.
- Liang PH, Wu CY, Greenberg WA, Wong CH. Glycan arrays: biological and medical applications. Curr Opin Chem Biol. 2008 Feb;12(1):86‑92. doi: 10.1016/j.cbpa.2008.01.031. Epub 2008 Mar 4. PMID: 18258211; PMCID: PMC7108407.
- Madera M, Mechref Y, Klouckova I, Novotny MV. Semiautomated high‑sensitivity profiling of human blood serum glycoproteins through lectin preconcentration and multidimensional chromatography/tandem mass spectrometry. J Proteome Res. 2006 Sep;5(9):2348‑63. doi: 10.1021/pr060169x. PMID: 16944947.
- Ritchie G, Harvey DJ, Feldmann F, Stroeher U, Feldmann H, Royle L, Dwek RA, Rudd PM. Identification of N‑linked carbohydrates from severe acute respiratory syndrome (SARS) spike glycoprotein. Virology. 2010 Apr 10;399(2):257‑69. doi: 10.1016/j.virol.2009.12.020. Epub 2010 Feb 2. PMID: 20129637; PMCID: PMC3412594.
- Park S, Lee MR, Pyo SJ, Shin I. Carbohydrate chips for studying high‑throughput carbohydrate‑protein interactions. J Am Chem Soc. 2004 Apr 21;126(15):4812‑9. doi: 10.1021/ja0391661. Erratum in: J Am Chem Soc. 2004 Sep 1;126(34):10794. PMID: 15080685.